Literature DB >> 23374616

Preventing adverse drug-drug interactions: a need for improved data and logistics.

Michael J Seminerio, Mark J Ratain.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23374616     DOI： 10.1016/j.mayocp.2012.12.005

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  2 in total

1.  A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients.

Authors:  Nimish Patel; Mona Nasiri; Arden Koroglu; Steven Bliss; Melissa Davis; Louise-Anne McNutt; Christopher Miller
Journal:  Infect Dis Ther       Date:  2015-01-28

Review 2.  Metabolism-related pharmacokinetic drug-drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations.

Authors:  Yi Ling Teo; Han Kiat Ho; Alexandre Chan
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.